First-line Treatment Selection for Advanced Hepatocellular Carcinoma
Canadian Oncology Today · 2024
DOI: 10.58931/cot.2024.1325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Oncology Today, 2024. Verfasst von Zainab Al Maqrashi und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The treatment landscape of advanced/unresectable hepatocellular carcinoma (uHCC) has rapidly evolved since 2018. Over recent years, various systemic therapies and treatment approaches have been explored. Systemic therapy has primarily relied on tyrosine kinase inhibitors (TKIs); however, immune checkpoint inhibitors (ICIs) have more recently entered the realm of the treatment armamentarium.
Zitieren
APA
Maqrashi, Z. A., & Meyers, B. M. (2024). First-line Treatment Selection for Advanced Hepatocellular Carcinoma. Canadian Oncology Today. https://doi.org/10.58931/cot.2024.1325
Vancouver
Maqrashi ZA, Meyers BM. First-line Treatment Selection for Advanced Hepatocellular Carcinoma. Canadian Oncology Today. 2024. doi:10.58931/cot.2024.1325
BibTeX
@article{Maqrashi2024,
author = {Maqrashi, Zainab Al and Meyers, Brandon M.},
title = {First-line Treatment Selection for Advanced Hepatocellular Carcinoma},
journal = {Canadian Oncology Today},
year = {2024},
doi = {10.58931/cot.2024.1325}
}
EUVIMED